Recommendations for the use of early cost-effectiveness analysis to inform the health technology development process with an application to cutaneous squamous cell carcinoma
eCEA can systematically inform technology development through value-based price estimation, value driver identification, and evidence prioritization. Implementing development decision-making based on eCEA insights can foster alignment with value-based principles of HTA-orientated decision-making systems while supporting more efficient resource allocation in technology development.
Authors
- Bikramaditya Ghosh (ORCID: https://orcid.org/0000-0003-0686-7046)
- R Mahon
- Abhirup Dutta Majumdar (ORCID: https://orcid.org/0009-0005-3812-6623)
- Saswata Paul Choudhury
- Anns Thomas
- Sekhar Kumar Dutta
- Debalina Dey
- Chetna Demla
Institutions
- Ollscoil na Gaillimhe – University of Galway (IE)
- Institute of Technology Assessment (AT)
- Clinical Insights (US)
- Pharmaplant (Germany) (DE)
Publication Details
- Journal
- International Journal of Technology Assessment in Health Care
- Published
- 2025-12-12
- DOI
- https://doi.org/10.1017/s0266462325103334
- Primary Topic
- Health Systems, Economic Evaluations, Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 0.00